SUPPLEMENT

Q1 FY2027 — Non-GAAP reconciliation (Reg G)

Q1 FY2027PDF · 4 pages209 KB
1
The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures
The following provides definitions of the non-GAAP measures used in Procter & Gamble's (“the Company”) October 22, 2026 earnings
call, associated slides and other materials and the reconciliation to the most closely related GAAP measure. We believe that these non-
GAAP measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and
results and provide a supplemental measure of year-on-year results.
The non-GAAP measures described below are used by Management in making operating decisions, allocating financial resources and
for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business
performance and provide investors a view of our business results through the eyes of Management. Certain of these measures are also
used to evaluate senior management and are a factor in determining their at-risk compensation.
These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as
supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other
companies due to possible differences in method and in the items or events being adjusted.
The Company is not able to reconcile its forward-looking non-GAAP cash flow and effective tax rate measures because the Company
cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP
results. Note that certain columns and rows may not add due to rounding.
The following measures are provided:
1. 	Organic sales growth — page 2
2. 	Core EPS and Currency-neutral Core EPS — page 3
3. 	Core gross margin and Currency-neutral Core gross margin — page 3
4. 	Core operating margin and Currency-neutral Core operating margin — page 4
5. 	Free cash flow and Free cash flow productivity — page 4
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable
for the following items:
• 	Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of approximately $250 -
$500 million before tax annually. In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio
and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $2 billion in
before-tax restructuring costs over two years and has incurred over half of the costs under this plan in fiscal 2026, with the remainder
expected to be incurred in fiscal 2027. The adjustment to Core earnings includes the restructuring charges that exceed the normal,
recurring level of restructuring charges.
• 	Glad joint venture agreement: In January 2026, the Glad joint venture agreement between the Company and Clorox expired. Under
the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair market value, for $476 million.
This transaction was accounted for as a dissolution of the Glad joint venture business and the Company recorded an after-tax gain
of $261 million.
We do not view the above items to be part of our sustainable results, and its exclusion from Core earnings measures provides a more
comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-
risk compensation.
Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and
divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental
understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is also used in assessing the
achievement of management goals for at-risk compensation.
Core EPS and currency-neutral Core EPS: Core net earnings per share, or Core EPS, is a measure of diluted net earnings per common
share (diluted EPS) adjusted for items as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the
incremental current year impact of foreign exchange. Management views these non-GAAP measures as useful supplemental measures
of Company performance over time. These measures are also used in assessing the achievement of management goals for at-risk
compensation.
Core gross margin and currency-neutral Core gross margin: Core gross margin is a measure of the Company's gross margin adjusted for
items as indicated. Currency-neutral Core gross margin is a measure of the Company's Core gross margin excluding the incremental
current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the
Company’s operating efficiency over time.

-- 1 of 4 --

2
Core operating margin and currency-neutral Core operating margin: Core operating margin is a measure of the Company's operating
margin adjusted for items as indicated. Currency-neutral Core operating margin is a measure of the Company’s Core operating margin
excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a
supplemental perspective to the Company’s operating efficiency over time.
Free cash flow: Free cash flow is defined as operating cash flow less capital spending. Free cash flow represents the cash that the
Company is able to generate after taking into account planned maintenance and asset expansion. We view free cash flow as an important
measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and
other discretionary investments.
Free cash flow productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. We view free cash flow
productivity as a useful measure to help investors understand P&G’s ability to generate cash. This measure is used by management in
making operating decisions, allocating financial resources and for budget planning purposes. This measure is also used in assessing the
achievement of management goals for at-risk compensation.
1. Organic sales growth:
Three Months Ended
September 30, 2026
Net Sales
Growth
Foreign Exchange
Impact
Acquisition &
Divestiture Impact
Organic Sales
Growth
Beauty 	6.4% 	(1.1)% 	—% 	5.4%
Grooming 	4.0% 	0.4% 	0.2% 	4.5%
Health Care 	3.1% 	(0.4)% 	—% 	2.7%
Fabric Care & Home Care 	4.2% 	0.6% 	—% 	4.8%
Baby, Feminine & Family Care 	2.9% 	0.1% 	—% 	3.0%
Total Company 	4.0% 	—% 	—% 	4.0%
Prior Quarters
Total Company
Net Sales
Growth
Foreign Exchange
Impact
Acquisition &
Divestiture Impact
Organic Sales
Growth
Q4 FY 2026 	1.5% 	(1.1)% 	—% 	0.5%
Q3 FY 2026 	7.4% 	(3.9)% 	—% 	3.5%
Q2 FY 2026 	1.5% 	(1.4)% 	—% 	—%
Q1 FY 2026 	3.0% 	(1.3)% 	—% 	1.6%
Guidance
Total Company 	Net Sales Growth
Combined Foreign Exchange and
Acquisition & Divestiture Impact* 	Organic Sales Growth
FY 2027 (Estimate) 	+2% to +4% 	-1% 	+1% to +3%
* Combined Foreign Exchange and Acquisition & Divestiture Impact includes foreign exchange impacts and the volume and mix impact of acquisitions and
divestitures.

-- 2 of 4 --

3
2. Core EPS and Currency-neutral Core EPS:
Three Months Ended September 30
2026 	2025
Diluted EPS 	$1.97 	$1.95
Incremental restructuring 	0.03 	0.04
Core EPS 	$2.00 	$1.99
Percentage change vs. prior period Core EPS 	1%
Currency impact to earnings 	(0.01)
Currency-Neutral Core EPS 	$1.99
Percentage change vs. prior period Core EPS 	—%
Prior Quarters
Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.
Guidance
Total Company
Diluted EPS
Growth
Impact of Incremental
Non-Core Items*
Core EPS
Growth 	Impact of FX
Currency-neutral Core
EPS Growth
FY 2027
(Estimate) +1% to +5% 	-1% to -2% 	—% to +3% 	—% 	—% to +3%
* Includes the impact of incremental non-core restructuring charges including the portfolio and productivity plan.
3. Core gross margin and Currency-neutral Core gross margin:
Three Months Ended September 30
2026 	2025
Gross Margin 	49.8% 	51.4%
Incremental restructuring 	0.2% 	0.1%
Core Gross Margin 	50.0% 	51.5%
Basis point change vs. prior year Core gross margin 	(150)
Currency Impact to Margin 	—
Currency-Neutral Core Gross Margin 	50.0%
Basis point change vs prior year Core gross margin 	(150)
Q1
FY26
Q1
FY25
Q2
FY26
Q2
FY25
Q3
FY26
Q3
FY25
Q4
FY26
Q4
FY25
Diluted EPS 	$1.95 	$1.61 	$1.78 	$1.88 	$1.63 	$1.54 	$1.26 	$1.48
Incremental restructuring 	0.04 	0.32 	0.10 	— 	0.07 	— 	0.16 	—
Glad joint venture agreement 	— 	— 	— 	— 	(0.11) 	— 	— 	—
Core EPS 	$1.99 	$1.93 	$1.88 	$1.88 	$1.59 	$1.54 	$1.43 	$1.48
Percentage change vs. prior 	3% 	—% 	3% 	(3)%
Currency Impact to Earnings 	— 	(0.03) 	(0.05) 	(0.02)
Currency-Neutral Core EPS 	$1.99 	$1.85 	$1.54 	$1.41
Percentage change vs. prior
period Core EPS 3% 	(2)% 	—% 	(5)%

-- 3 of 4 --

4
4. Core operating margin and Currency-neutral Core operating margin:
Three Months Ended September 30
2026 	2025
Operating Margin 	25.5% 	26.2%
Incremental restructuring 	0.4% 	0.5%
Core Operating Margin 	25.9% 	26.7%
Basis point change vs. prior year Core operating margin 	(80)
Currency Impact to Margin 	(0.1)%
Currency-Neutral Core Operating Margin 	25.8%
Basis point change vs. prior year Core operating margin 	(90)
5. Free cash flow and Free cash flow productivity (dollar amounts in millions):
Three Months Ended September 30, 2026
Operating Cash Flow 	Capital Spending 	Free Cash Flow 	Net Earnings Free Cash Flow
Productivity
$5,767 	$(1,366) 	$4,401 	$4,757 	93%

-- 4 of 4 --